Cytogel Pharma Obtains $2,691,190 New Funding

  • Feed Type
  • Date
    1/7/2015
  • Company Name
    Cytogel Pharma
  • Mailing Address
    3 Thorndal Circle Darien, CT 06820 USA
  • Company Description
    Cytogel Pharma (Cytogel) is a bio-pharmaceutical development company focused on acquiring promising early-stage programs that offer significant potential both as platform technologies and high value product candidates. The company’s portfolio includes novel analgesic product candidates and broadly useful polymer and hydrogel drug delivery platform technologies.
  • Website
    http://www.cytogelpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,691,190
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor